| J3262 | Injection, tocilizumab, 1 mg | 49,760 | $10 | $248.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 16,540 | $10 | $165.4K |
| J0897 | Injection, denosumab, 1 mg | 6,840 | $20 | $123.1K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,230 | $30 | $109.7K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,800 | $1 | $95.2K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,680 | $30 | $69.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 640 | $100 | $62.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 290 | $110 | $32K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $130 | $18.3K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 250 | $60 | $16.2K |